Medix Biochemica broadens product portfolio and further expands U.S. presence through acquisition of EastCoast Bio June 5, 2020
Medix Biochemica expands to Drugs of Abuse antibody and antigen manufacturing through acquisition of Biostride Inc. June 5, 2020
Medix Biochemica broadens product portfolio and further expands U.S. presence through acquisition of EastCoast Bio June 5, 2020
Medix Biochemica expands to Drugs of Abuse antibody and antigen manufacturing through acquisition of Biostride Inc. June 5, 2020